| Fecha de publicación | Título | Tipo de publicación/ Tipo de recurso | Autor(es) | Fecha de depósito |
| 2020 | Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses | Preimpreso | Jiang, S; Hillyer, C; Du, L | - |
| 2020 | Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID) | Preimpreso | Jin, X; Pang, B; Zhang, J; Liu, Q; Yang, Z; Feng, J; Liu, X; Zhang, L; Wang, B; Huang, Y; Josephine Fauci, A; Ma, Y; Soo Lee, M; Yuan, W; Xie, Y; Tang, J; Gao, R; Du, L; Zhang, S; Qi, H; Sun, Y; Zheng, W; Yang, F; Chua, H; Wang, K; Ou, Y; Huang, M; Zhu, Y; Yu, J; Tian, J; Zhao, M; Hu, J; Yao, C; Li, Y; Zhang, B | - |
| 2020 | Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses | Preimpreso | Wang, N; Shang, J; Jiang, S; Du, L | - |
| 2019 | Enhanced ability of oligomeric nanobodies targeting MERS coronavirus receptor-binding domain | Preimpreso | He, L; Tai, W; Li, J; Chen, Y; Gao, Y; Li, J; Sun, S; Zhou, Y; Du, L; Zhao, G | - |
| 2019 | MERS Coronavirus: An emerging zoonotic virus | Preimpreso | Li, F; Du, L | - |
| 2019 | A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike | Preimpreso | Xia, S; Yan, L; Xu, W; Agrawal, A; Algaissi, A; Tseng, C; Wang, Q; Du, L; Tan, W; Wilson, I; Jiang, S; Yang, B; Lu, L | - |
| 2020 | Molecular mechanism for antibody-dependent enhancement of coronavirus entry | Preimpreso | Wan, Y; Shang, J; Sun, S; Tai, W; Chen, J; Geng, Q; He, L; Chen, Y; Wu, J; Shi, Z; Zhou, Y; Du, L; Li, F | - |
| 2020 | Management strategies of neonatal jaundice during the coronavirus disease 2019 outbreak | Preimpreso | Ma, X; Chen, Z; Zhu, J; Shen, X; Wu, M; Shi, L; Du, L; Fu, J; Shu, Q | - |
| 2020 | Comprehensive Genomic Characterization Analysis of lncRNAs in Cells With Porcine Delta Coronavirus Infection | Preimpreso | Liu, J; Wang, F; Du, L; Li, J; Yu, T; Jin, Y; Yan, Y; Zhou, J; Gu, J | - |
